Biocoral France is an international biomaterials company and exclusive manufacturer of Biocoral^® Products.

Biocoral France, develops, manufactures and markets bone graft (Biocoral^®)  and other bone growth products for orthopedic, oral and maxillofacial  applications to a number of countries outside the United States.

The company has also developed what the management believes is the world's first fully autologous biological glue.

The company has also completed the final stages of development of its product for treatment of bone fractures associated to osteoporosis and is continuing to work on prevention of such fractures.

Biocoral France received the authorization of marketing of Biocoral^® in the European countries "EC lable" on December 30, 1996. Since, this authorization has been renewed several times and it is into force currently.